Ron Cohen, President and CEO at ACORDA THERAPEUTICS INC (ACOR), sold 4,000 shares at $15.89 ($64K) on 2008-12-01, disclosed to the SEC on 2008-12-03.
Open-market sale of $64k ACOR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ACOR | SELL | 2019-12-04 | $8K | — | Filing → |
| ACOR | SELL | 2018-12-06 | $75K | — | Filing → |
| ACOR | BUY | 2017-06-20 | $339K | — | Filing → |